The collaboration connects Toshiba's document management strengths with Experion's product engineering to make workflows faster and audit-ready, laying the groundwork for broader innovation across Australia's supply chain sector
MELBOURNE, Australia, April 23, 2026 /PRNewswire/ -- Experion Technologies and Toshiba have partnered to accelerate workflow digitisation for organisations across Australia, starting with logistics and supply chain environments where speed, compliance, and consistency are critical. Together, they are helping Australian logistics and supply chain organisations modernise transportation claims handling and document management through a unified digital platform designed for speed, traceability, and scale.
The collaboration brings together Experion's product engineering and intelligent digital experience capabilities with Toshiba's domain leadership in document and workflow technologies, helping Australian organisations move from paper-heavy processes to connected, scalable ways of working. Beyond technology enablement, the partnership reflects a shared commitment to supporting Australian businesses as they respond to evolving customer expectations, governance requirements, and distributed operations across metro hubs and regional corridors.
Keith Anderson, Regional Manager (VIC), Toshiba Australia, shared, "This collaboration is about helping Australian organisations modernise with confidence. Together, we're providing a stronger pathway from capture to connected workflows, underpinned by reliability and scale."
Recent joint delivery milestones have reinforced the value of the partnership, demonstrating how the two organisations can work together to simplify day-to-day operations, strengthen audit readiness, and support workforce efficiency across multi-site environments. These results deepen the collaboration further and set the stage for an expanded roadmap in Australia. Initial implementations have demonstrated claims processing cycle-time reductions of up to 40–60%, while improving audit traceability and operational consistency across distributed operations.
For Experion, the strengthened partnership broadens its presence in Australia and reinforces its focus on long-term customer relationships built on platform thinking, engineering depth, and practical innovation. For Toshiba, the collaboration enhances its ability to deliver end-to-end digital workflow outcomes—extending beyond devices into enterprise-grade orchestration and integration.
Commenting on the collaboration, Satheesh Baskaran, Vice President & Region Head, Experion Technologies, said, "Australia is prioritising practical transformation—initiatives that reduce friction, strengthen governance, and support growth across distributed operations. Our partnership with Toshiba reflects that direction."
Looking ahead, Experion and Toshiba are aligned on future plans in Australia, expanding joint customer programs, strengthening enterprise integration pathways, and advancing automation that improves operational resilience—helping organisations scale without added complexity.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Experion and Toshiba Deepen Partnership to Cut Claims Turnaround by 40-60% for Australian Supply Chains
|
PISCATAWAY, N.J., April 23, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced that CEO Sherry Shao and Co-Founder Dr. Frank Zhang have been selected as finalists for the Entrepreneur Of The Year® 2026 New Jersey Award by Ernst & Young LLP.
The Entrepreneur Of The Year program is one of the world's most prestigious business awards for entrepreneurs and transformational leaders. For more than four decades, the program has recognized visionary leaders who build and sustain successful businesses through innovation, growth, resilience, and long-term impact.
Founded in New Jersey in 2002, GenScript has grown from a pioneering gene synthesis company into a global biotechnology enterprise serving customers in more than 100 countries. Today, GenScript supports researchers, biotechnology innovators, and pharmaceutical companies worldwide through solutions that accelerate discovery, development, and manufacturing.
The finalist recognition reflects the entrepreneurial leadership of Dr. Frank Zhang, who cofounded GenScript with a bold mission to make biotechnology more accessible and efficient, and Sherry Shao, whose leadership has helped guide the company through continued global growth and transformation.
"GenScript was built on the belief that scientific innovation can improve lives and shape a healthier future," said Sherry Shao, CEO of GenScript. "We are honored by this recognition, which belongs to the talented teams around the world whose dedication and passion continue to move our mission forward."
"This recognition is a reflection of the people of GenScript and the spirit of entrepreneurship that has defined our journey since the beginning," said Dr. Frank Zhang, Co-Founder of GenScript. "We remain committed to advancing biotechnology in ways that create meaningful value for customers, patients, and society."
Regional award winners will be announced at the Entrepreneur Of The Year 2026 New Jersey Awards celebration on June 4, 2026.
About GenScript
GenScript Biotech Corporation is a global biotechnology group with a mission to make people and nature healthier through biotechnology. Built on leading gene synthesis capabilities, GenScript has expanded into a broad portfolio of life science services and products that support innovation across research, therapeutics, and industrial applications.
Media Contact
Kate Grusich
Senior Corporate Communications Manager
Katherina.Grusich@genscript.com
Melis Inceer
Head of Integrated Communications & Content
Melis.Inceer@genscript.com
PISCATAWAY, N.J., April 23, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced that CEO Sherry Shao and Co-Founder Dr. Frank Zhang have been selected as finalists for the Entrepreneur Of The Year® 2026 New Jersey Award by Ernst & Young LLP.
The Entrepreneur Of The Year program is one of the world's most prestigious business awards for entrepreneurs and transformational leaders. For more than four decades, the program has recognized visionary leaders who build and sustain successful businesses through innovation, growth, resilience, and long-term impact.
Founded in New Jersey in 2002, GenScript has grown from a pioneering gene synthesis company into a global biotechnology enterprise serving customers in more than 100 countries. Today, GenScript supports researchers, biotechnology innovators, and pharmaceutical companies worldwide through solutions that accelerate discovery, development, and manufacturing.
The finalist recognition reflects the entrepreneurial leadership of Dr. Frank Zhang, who cofounded GenScript with a bold mission to make biotechnology more accessible and efficient, and Sherry Shao, whose leadership has helped guide the company through continued global growth and transformation.
"GenScript was built on the belief that scientific innovation can improve lives and shape a healthier future," said Sherry Shao, CEO of GenScript. "We are honored by this recognition, which belongs to the talented teams around the world whose dedication and passion continue to move our mission forward."
"This recognition is a reflection of the people of GenScript and the spirit of entrepreneurship that has defined our journey since the beginning," said Dr. Frank Zhang, Co-Founder of GenScript. "We remain committed to advancing biotechnology in ways that create meaningful value for customers, patients, and society."
Regional award winners will be announced at the Entrepreneur Of The Year 2026 New Jersey Awards celebration on June 4, 2026.
About GenScript
GenScript Biotech Corporation is a global biotechnology group with a mission to make people and nature healthier through biotechnology. Built on leading gene synthesis capabilities, GenScript has expanded into a broad portfolio of life science services and products that support innovation across research, therapeutics, and industrial applications.
Media Contact
Kate Grusich
Senior Corporate Communications Manager
Katherina.Grusich@genscript.com
Melis Inceer
Head of Integrated Communications & Content
Melis.Inceer@genscript.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
GenScript Leaders Named Entrepreneur Of The Year® 2026 New Jersey Finalists
GenScript Leaders Named Entrepreneur Of The Year® 2026 New Jersey Finalists
